Skip to main content

Table 1 Circle participants by eGFR* category and urine albumin testing

From: Prevalence, determinants and co-morbidities of chronic kidney disease among First Nations adults with diabetes: results from the CIRCLE study

Participant Numbers

Total

eGFR = > 90

eGFR 60 to <90

eGFR 30 to <60

eGFR 15 to <30

eGFR <15 (no RRT**)

eGFR <15 (RRT)

  

Non/Stage 1 CKD

Non/Stage 2 CKD

Stage 3 CKD

Stage 4 CKD

Stage 5a CKD

Stage 5b CKD

People with eGFR (% total)

850

451 (53.1)

267 (31.4)

105 (12.4)

13 (1.5)

6 (0.7)

8 (0.9)

People with eGFR & Urine Albumin Test (% total)

685

367 (53.5)

216 (31.5)

84 (12.3)

10 (1.5)

4 (0.6)

4 (0.6)

Normal Urine Albumin (% in eGFR Stage)

274

147 (40.1)

95 (44.0)

30 (35.7)

1 (10)

1 (25)

0 (0)

Micro-albuminuria (% in eGFR Stage)

278

159 (43.3)

88 (40.7)

29 (34.5)

2 (20)

0 (0)

0 (0)

Macro-albuminuria (% in eGFR Stage)

133

61 (16.6)

33 (15.3)

25 (29.8)

7 (70)

3 (75)

4 (100)

Micro/Macro-albuminuria (% in eGFR Stage)

411

220 (59.9)

121 (56.0)

54 (64.3)

9 (90)

3 (75)

4 (100)

People included in further analyses (% total)***

715

367 (51.3)

216 (30.2)

105 (14.7)

13 (1.8)

6 (0.8)

8 (1.1)

  1. *Estimated glomerular filtration rates in ml/min/1.73 m2 – categories correspond to Chronic Kidney Disease (CKD) Stages. Those with eGFRs = > 60 and no albuminuria are non-CKD. Stage 1 plus Stage 2 = CKD-alb. Stages 3-5b = CKD-eGFR <60.
  2. **Renal replacement therapy.
  3. ***Those with eGFR = > 60 and a urine albumin test plus those with eGFR <60 with or without urine albumin test (Numbers in bold.)